Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine (VSG-2011-101)

This study has been completed.
Sponsor:
Collaborators:
Karolinska Institutet
Pharma Consulting Group AB
Information provided by (Responsible Party):
Viscogel AB
ClinicalTrials.gov Identifier:
NCT01578070
First received: April 11, 2012
Last updated: August 29, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
No publications provided by Viscogel AB

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):